Myoinositol Plus L-tyrosine, Selenium and Chromium in PCOS

PHARMARTE

Status: Completed

Conditions: Polycystic Ovary Syndrome; Hirsutism; Menstrual Problem

Treatments: Dietary Supplement: Myo-inositol+L-tyrosine

Study type: Interventional

Funder types: Industry

Identifiers

NCT03673995

PharmarteLtyrosine1

Details and patient eligibility

About

PCOS patients were treated every day, with one sachet containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid. All patients underwent, before starting the therapy, after 3 months and 6 months, hormonal evaluation , hirsutism scoring and ovulation assesment. Most of them during the treatment improved their symptoms.

Enrollment: 186 patients

Sex: Female

Ages: 16 to 38 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

° PCOS patients

Exclusion criteria

• thyroid dysfunction
• hyperprolactinemia
• adrenal hyperplasia
• patients taking oral contraceptive
• any other endocrinological pathologies

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

186 participants in 1 patient group

Myo-inositol+L-tyrosine

Experimental group

Description:

One sachet per day containing 2000 mg myo-inositol, 500 mg L-tyrosine, 40 mcg chromium picolinate, 55 mcg selenium, 200 mcg folic acid for improving PCOS symptoms.

Treatment:

Dietary Supplement: Myo-inositol+L-tyrosine